NCT01556841 The Activity of TroVax® Versus Placebo in Relapsed Asymptomatic Ovarian Cancer Status COMPLETED Phase PHASE2
NCT01551459 A Phase II Study of Sunitinib Versus Dacarbazine in the Treatment of Patients With Metastatic Uveal Melanoma Status COMPLETED Phase PHASE2
NCT01460888 Radiotherapy & Olaparib in COmbination for Carcinoma of the Oesophagus Status UNKNOWN Phase PHASE1
NCT01431664 AT9283 in Treating Young Patients With Relapsed or Refractory Acute Leukemia Status COMPLETED Phase PHASE1
NCT01398085 IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT01390571 Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma Status COMPLETED Phase PHASE1
NCT01331525 The Addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for Extensive Stage Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT01324115 NG-Nitro-L-Arginine in Treating Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT01303887 A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients Status COMPLETED Phase PHASE3
NCT01279967 A Clinical Trial of ADI-PEG 20TM in Patients With Malignant Pleural Mesothelioma Status UNKNOWN Phase PHASE2
NCT01263171 Oxaliplatin, Leucovorin, and Fluorouracil Before and After Radiation Therapy and Surgery in Treating Patients With Rectal Cancer That Can Be Removed by Surgery Status COMPLETED Phase PHASE2
NCT01233492 Boron Phenylalanine With or Without Mannitol in Treating Patients With Glioblastoma Multiforme Status TERMINATED Phase PHASE1
NCT01222221 Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Status COMPLETED Phase PHASE1
NCT01212887 Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer Status TERMINATED Phase PHASE1
NCT01196741 Saracatinib and Paclitaxel in Platinum-resistant Ovarian Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT01196715 Comparison Study of Standard Care Against Combination of Growth Factors Agents for Low-risk Myelodysplastic Syndromes Status COMPLETED Phase PHASE3
NCT01171378 Study of Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone (CHOP) With Ofatumumab in Patients With Richter's Syndrome Status COMPLETED Phase PHASE2